rss
J Med Ethics 2005;31:251-255 doi:10.1136/jme.2003.007435
  • Clinical ethics

Methodological quality and reporting of ethical requirements in phase III cancer trials

  1. J J Tuech1,2,
  2. P Pessaux3,
  3. G Moutel1,
  4. V Thoma4,
  5. S Schraub1,4,
  6. C Herve1
  1. 1Laboratoire d’Ethique Médicale et de Santé Publique, Faculté de Médecine Necker, Université Paris René Descartes, France
  2. 2Department of Digestive Surgery, University Hospital, France
  3. 3Département de Statistiques Bio-médicales, CHU Angers, France
  4. 4CRLCC Paul Strauss, Strasbourg, France
  1. Correspondence to:
 J J Tuech
 Service de Chirurgie Digestive, Centre Hospitalier de Mulhouse, E-muller-moenchberg, 20 rue dr Laennec, 68070 Mulhouse cedex 1, France; tuechjch-mulhouse.fr
  • Received 18 November 2003
  • Accepted 2 March 2004
  • Revised 14 February 2004

Abstract

Background: The approval of a research ethics committee (REC) and obtaining informed consent from patients (ICP) could be considered the main issues in the ethics of research with human beings. The aim of this study was to assess both methodological quality and ethical quality, and also to assess the relationship between these two qualities in randomised phase III cancer trials.

Method: Methodological quality (Jadad score) and ethical quality (Berdeu score) were assessed for all randomised controlled trials (RCTs) published in 10 international journals between 1999 and 2001 (n  =  231).

Results: The mean Jadad score was 9.86 ± 1.117. The methodological quality was poor in 75 RCTs (Jadad score <9). The mean Berdeu score was 0.42 ± 0.133. The mean ethical quality score for poor methodological quality RCTs (n  =  75) was 0.39 ± 0.133; it was 0.43 ± 0.133 for good (n  =  156) methodological quality RCTs (p  =  0.07). There was improvement in ethical quality according to the year of commencement of the trials (p < 0.001). There was no correlation between methodological quality and the number of participating patients (R2  =  0.003, p  =  0.78), between ethical quality and the number of participating patients (R2  =  0.003, p  =  0.76 ), or between ethical quality and methodological quality (R2  =  0.012, p  =  0.1). ICP and REC approval were not obtained for 21 and 77 trials respectively.

Conclusion: The association between methodological quality and the reporting of ethical requirements probably reflects the respect shown for patients during the whole research process. These results suggest that closer attention to the conduct of clinical research, as well as the reporting of its ethical aspects, is needed.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.